Samsung Pharmaceutical has ranked among the top searched stocks for 14 days in the past month.


As of 10:30 AM on the 19th, Samsung Pharmaceutical is trading at 8,350 KRW, down 5.11% from the previous day. This represents an 88.49% increase compared to December 23. Samsung Pharmaceutical is known as a leading pharmaceutical company specializing in over-the-counter drugs such as Gas Myungsoo.

Today, foreigners have a net purchase of 57,276 shares of Samsung Pharmaceutical, while institutions have a net sale of 11,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 70,151 shares, while foreigners and institutions have net sold 2,849 shares and 591 shares, respectively.


On January 12, Samsung Pharmaceutical became a market issue with the headline "Where is the expectation for pancreatic cancer treatment? Sudden plunge."




[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing